Minbin Yu

Minbin Yu

Auto-generated profile, based on publicly available information

Minbin Yu

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2011 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Closed access
PDF file
JLJingrong Li
Jingrong Li
Benjamin ThompsonBenjamin Thompson
Benjamin Thompson
Carly Siu Yin LamCarly Siu Yin Lam
Carly Siu Yin Lam
DDDaming Deng
Daming Deng
LCLily Chan
Lily Chan
RHRobert F. Hess
Robert F. Hess
Purpose.: This study had three main goals: to assess the degree of suppression in patients with strabismic, anisometropic, and mixed amblyopia; to establish the relationship between suppression and the degree of amblyopia; and to compare the degree of suppression across the clinical subgroups within the sample. Methods.: Using both standard measures of suppression (Bagolini lenses and neutral density [ND] filters, Worth 4-Dot test) and a new approach involving the measurement of dichoptic motion thresholds under conditions of variable interocular contrast, the degree of suppression in 43 amblyopic patients with strabismus, anisometropia, or a combination of both was quantified. Results.: There was good agreement between the quantitative measures of suppression made with the new dichoptic motion threshold technique and measurements made with standard clinical techniques (Bagolini lenses and ND filters, Worth 4-Dot test). The degree of suppression was found to correlate directly with the degree of amblyopia within our clinical sample, whereby stronger suppression was associated with a greater difference in interocular acuity and poorer stereoacuity. Suppression was not related to the type or angle of strabismus when this was present or the previous treatment history. Conclusions.: These results suggest that suppression may have a primary role in the amblyopia syndrome and therefore have implications for the treatment of amblyopia.

1 August 2009 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Closed access
PDF file
XLXianchai Lin
Xianchai Lin
MYMinbin Yu
Minbin Yu
KWKaili Wu
Kaili Wu
HYHongzhi Yuan
Hongzhi Yuan
HZHua Zhong
Hua Zhong
Purpose. To investigate the effect of pirfenidone, a novel antifibrotic agent, on proliferation, migration, and collagen contraction of human Tenon’s fibroblasts (HTFs). methods. After treatment of HTFs with pirfenidone, cell proliferation was measured by MTT assay. Cell migration was investigated by scratch assay. Contractility was evaluated in fibroblast-populated collagen gels. Cell viability was determined by trypan blue exclusion assay. The expression of TGF-β1, -β2, and -β3 was estimated with RT-PCR, Western blot, and immunofluorescence analyses. results. Pirfenidone induced significant dose-dependent inhibition of HTF proliferation and migration and collagen contraction. After treatment with different concentrations of pirfenidone (0.15, 0.3, and 1 mg/mL) for 24 and 72 hours, cell viability was not different in the treatment and control groups. After 24 hours of treatment with pirfenidone, HTFs showed dose-dependent decreases in mRNA and protein levels of TGF-β1, -β2, and -β3. conclusions. These findings indicate that pirfenidone inhibits proliferation, migration, and collagen contraction of HTFs at nontoxic concentrations. A decrease in autocrine TGF-β signaling may have a role in the effects of pirfenidone.

16 July 2013 in Neurotherapeutics
Verified
Journal Article
Closed access
PDF file
DSDaniel P. Spiegel
Daniel P. Spiegel
JLJinrong Li
Jinrong Li
RHRobert F. Hess
Robert F. Hess
WBWinston D. Byblow
Winston D. Byblow
DDDaming Deng
Daming Deng
Benjamin ThompsonBenjamin Thompson
Benjamin Thompson

1 December 2010 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Closed access
PDF file
JLJingrong Li
Jingrong Li
Carly Siu Yin LamCarly Siu Yin Lam
Carly Siu Yin Lam
MYMinbin Yu
Minbin Yu
RHRobert F. Hess
Robert F. Hess
LCLily Chan
Lily Chan
Benjamin ThompsonBenjamin Thompson
Benjamin Thompson
Purpose.: Although eye dominance assessment is used to assist clinical decision-making, current understanding is limited by inconsistencies across the range of available tests. A new psychophysical test of sensory eye dominance has been developed that objectively measures the relative contribution of each eye to a fused suprathreshold binocular percept. Methods.: Six standard tests and the newly developed test were used to measure motor and sensory dominance in a group of 44 binocularly normal individuals (mean age, 29.5 ± 9.10 years). The new test required observers to perform a motion coherence task under dichoptic viewing conditions, wherein a population of moving, luminance-defined signal (coherently moving) and noise (randomly moving) dots were presented separately to each eye. The observers judged the motion direction of the signal dots. Motion coherence thresholds were measured by varying the ratio of signal-to-noise dots, in a staircase procedure. Results.: The new dichoptic motion coherence threshold test revealed a clear bimodal distribution of sensory eye dominance strength, wherein the majority of the participants (61%) showed weak dominance, but a significant minority (39%) showed strong dominance. Subsequent analysis revealed that the strong-dominance group showed greater consistency across the range of traditional eye dominance tests used. Conclusions.: This new quantitative dichoptic motion coherence threshold technique suggests that there are two separate sensory eye dominance strength distributions among observers with normal binocular vision: weak and strong eye dominance. This finding may provide a basis for clinical decision-making by indicating whether eye dominance is likely to be an important consideration in a particular patient.

1 May 2011 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Closed access
PDF file
HZHua Zhong
Hua Zhong
GSGuoying Sun
Guoying Sun
XLXianchai Lin
Xianchai Lin
KWKaili Wu
Kaili Wu
MYMinbin Yu
Minbin Yu
Purpose.: To investigate whether topical administration of pirfenidone eye drops could be used to prevent postoperative scarring in a rabbit model of experimental glaucoma filtration surgery. Methods.: In a randomized, controlled, masked-observer study, 40 rabbits underwent trabeculectomy in the right eyes and randomly received postoperative administration of 0.1% or 0.5% pirfenidone, perioperative mitomycin C (0.25 mg/mL), or no treatment. Bleb characteristics and functions were evaluated over a period of 4 weeks. The animals were killed on days 7, 14, and 28. Histopathology and immunohistochemistry were performed to determine the amount of scarring and fibrosis. Ocular toxicity was assessed by the Draize test, histopathology, and electron microscope. Results.: The four treatment groups were similar with respect to intraocular pressure and anterior chamber depth. Pirfenidone 0.5% significantly prolonged bleb survival, and the blebs were larger and higher than those in the control group (P < 0.05); the 0.1% pirfenidone concentration was less effective. Furthermore, the histology and immunohistology results showed that the 0.5% pirfenidone and mitomycin C groups had less scarring at days 7 to 28 than did the controls. Toxicity assessments showed that pirfenidone did not damage the rabbit eyes. Conclusions.: Postoperative use of 0.5% pirfenidone eye drops was associated with improved trabeculectomy bleb survival in a rabbit model. Pirfenidone eye drops may be a safe and effective antiscarring agent in glaucoma filtration surgery.

1 September 2012 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Closed access
PDF file
HZHua Zhong
Hua Zhong
XCXueping Cha
Xueping Cha
TWTao Wei
Tao Wei
XLXianchai Lin
Xianchai Lin
XLXun Li
Xun Li
YYYuansheng Yuan
Yuansheng Yuan
Purpose.: The purpose of the study was to describe the prevalence, severity, and associated risk factors for pterygium in a population-based sample of rural residents of the Bai minority population in rural Dali, China. Methods.: A population-based survey of Chinese Bai Nationality aged ≥50 years from randomly selected block groups in southwestern China was conducted. A clinical examination by experienced ophthalmologists was carried out, and the presence of pterygium was diagnosed at the examination. Pterygium was graded clinically by slit lamp examination. Questionnaires were conducted on risk factors. Results.: From a total of 2742 eligible subjects, 2133 (77.8%) were examined. The prevalence of pterygium was high (overall 39.0% [95% confidence interval (CI) 37.0–41.0]). Women had a higher rate than men (27.3% vs. 11.7%, respectively). In multivariate analysis, pterygium was independently associated with increasing age (odds ratio [OR] 1.55 [95% CI 1.24–1.93], 1.47 [95% CI 1.13–1.91], and 1.79 [95% CI 1.17–2.73], respectively, for persons 60–69 years, 70–79 years, and 80 years and older compared with 50–59 years), female sex (OR 1.42 [95% CI 1.08–1.88]), lack of formal education (OR 1.26 [95% CI 1.03–1.56]), and presence of outdoor work (OR 1.51 [95% CI 1.10–1.92]). Height, weight, hypertension, diabetes, smoking, and alcohol use history were not associated with pterygium. Conclusions.: The prevalence of pterygium in Dali is 39.0% among Chinese Bai aged 50 years and older. Independent associations with increasing age (>59 years), female sex, lack of education, and occupations linked to outdoor work suggest a multifactorial cause of this condition.